
Faculty, Staff and Student Publications
Publication Date
12-2-2022
Journal
Cancer Research
Abstract
Autophagy is an attractive therapeutic target in cancer. Successful autophagy-focused clinical intervention will require a detailed understanding of when and where autophagy is important during tumorigenesis. In this issue of Cancer Research, Khayati and colleagues use state-of-the-art genetically engineered mouse models to demonstrate that transient systemic inhibition of autophagy can irreversibly impair the growth of established lung tumors with a good tolerability in normal tissues, suggesting a therapeutic strategy for cancer treatment.
Keywords
Animals, Mice, Immunotherapy, Lung Neoplasms, Autophagy, Carcinogenesis, Cell Transformation, Neoplastic
DOI
10.1158/0008-5472.CAN-22-3024
PMID
36458406
PMCID
PMC9720714
PubMedCentral® Posted Date
June 2023
PubMedCentral® Full Text Version
Author MSS
Published Open-Access
yes
Included in
Bioinformatics Commons, Biomedical Informatics Commons, Medical Sciences Commons, Oncology Commons
Comments
PMID: 36458406